Zivo Bioscience Inc.

01/23/2025 | Press release | Distributed by Public on 01/23/2025 18:48

Annual Statement of Changes in Beneficial Ownership (Form 5)

Ownership Submission
FORM 5
Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Form 3 Holdings Reported
Form 4 Transactions Reported
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0362 Expires: January 31, 2005 Estimated average burden hours per response... 1.0
1. Name and Address of Reporting Person *
STROME MARK E
2. Issuer Name and Ticker or Trading Symbol
Zivo Bioscience, Inc. [ZIVO] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
C/O STROME GROUP, INC. , 13535 VENTURA BLVD., STE C-525
3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
2024-12-31
(Street)
SHERMAN OAKS CA 91423
4. If Amendment, Date Original Filed (Month/Day/Year)
 6. Individual or Join/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code 4. Securities Acquired (A) or Disposed of (D) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) 6. Ownership Form: Direct (D) or Indirect (I) 7. Nature of Indirect Beneficial Ownership
Amount (A) or (D) Price
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code 5. Number of Derivative Securities Acquired (A) or Disposed of (D) 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security 8. Price of Derivative Security 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) 11. Nature of Indirect Beneficial Ownership
(A) (D) Date Exercisable Expriation Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
STROME MARK E
C/O STROME GROUP, INC.
13535 VENTURA BLVD., STE C-525
SHERMAN OAKS, CA91423 		X
STROME INVESTMENT MANAGEMENT LP
C/O STROME GROUP, INC.
13535 VENTURA BLVD., STE C-525
SHERMAN OAKS, CA91423 		Affiliate of 10% Owner
STROME GROUP, INC.
13535 VENTURA BLVD., STE C-525

SHERMAN OAKS, CA91423 		Affiliate of 10% Owner

Signatures

/s/ Mark E. Strome 2025-01-23
**Signature of Reporting Person Date
/s/ Mark E. Strome, as President of General Partner, on behalf of Strome Investment Management, LP 2025-01-23
**Signature of Reporting Person Date
/s/ Mark E. Strome, as President of General Partner, on behalf of Strome Group, Inc. 2025-01-23
**Signature of Reporting Person Date

Explanation of Responses:

(*) If the form is filed by more than one reporting person, see Instruction 5(b)(v).
(**) Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The reported securities are owned directly by Strome Mezzanine Fund II, LP ("SMF II).
(2) Strome Investment Management, LP is the general partner of SMF II. Strome Group, Inc. is the general partner of Strome Investment Management, LP. Mark E. Strome is the President and CEO of Strome Group, Inc. Mr. Strome, Strome Investment Management, LP and Strome Group, Inc. (together, the "Reporting Persons") may be deemed to share voting and investment power for and to beneficially own the shares held by SMF under Section 13(d) of the Securities Exchange Act of 1934 (the "Exchange Act").
(3) Pursuant to Rule 16a-1(a)(4) of the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities reported herein.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.